| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $207 | — | +0.0% |
| R&D Expense | $80K | +5.6% | -53.3% |
| SG&A Expense | $291K | -42.9% | -8.9% |
| Operating Income | -$371K | +36.6% | +24.5% |
| Interest Expense | $33K | +426.1% | +94.1% |
| Pre-tax Income | $31K | +104.8% | +103.5% |
| Net Income | $31K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $5K | +48.6% | — |
| Current Assets | $253K | -36.9% | +84.7% |
| Total Assets | $262K | -34.8% | +91.1% |
| Current Liabilities | $3.6M | -6.1% | +44.9% |
| Total Liabilities | $3.6M | -6.1% | +44.9% |
| Stockholders' Equity | -$3.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$632K | — | — |
| Investing Cash Flow | -$9K | — | — |
| Financing Cash Flow | $637K | — | — |
| +104.8% |
| +103.5% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| +2.7% |
| -42.2% |